數位乳房攝影市場－全球產業規模、佔有率、趨勢、機會、預測：按產品、最終用戶、地區和競爭對手分類，2021-2031年

全球數位乳房攝影市場預計將從2025年的11.9億美元大幅成長到2031年的20.5億美元，複合年成長率為9.49%。

這種特殊的影像技術利用固體檢測器將X光能量轉換為電訊號，進而偵測乳房異常。推動該成長要素包括全球乳癌發生率的不斷上升，這需要有效的早期檢測方法，以及政府主導的篩檢計畫的擴展。女性人口老化也加劇了這項需求，因為年齡是乳癌的主要風險因素。例如，美國癌症協會估計，到2025年，美國女性將新增316,950例侵襲性乳癌病例，凸顯了普及篩檢技術的迫切需求。然而，數位乳房X光攝影系統高昂的初始成本和營運成本阻礙了市場擴張。這些沉重的經濟負擔是市場成長的主要障礙，尤其是在醫療預算有限、保險對先進診斷程序的報銷往往不足的開發中國家。這些經濟限制制約了資源匱乏地區對數位乳房乳房X光攝影設備的採用，從而阻礙了這項技術在全球範圍內的推廣。

市場促進因素

將人工智慧 (AI) 應用於乳房攝影影像技術是全球數位乳房乳房X光攝影市場的重要驅動力，顯著提高了診斷準確性和營運效率。透過將深度學習演算法與人工分析相結合，AI 可以幫助醫療專業人員減少假陽性結果，提高早期檢出率，從而加速與這些先進軟體工具相容的先進數位系統的普及。近期臨床證據也支持這項技術優勢。例如，RadNet 公司於 2025 年 11 月進行的一項「AI 輔助安全審查評估」研究表明，與標準 3D乳房X光攝影相比，AI 驅動的工作流程可將乳癌檢出率提高 21.6%。這些進步正促使醫療機構升級設備，使其能夠在有效管理不斷成長的患者數量的同時，提供更高品質的醫療服務。同時，政府資助的乳癌篩檢舉措的建立和擴展也為市場需求奠定了穩定的基礎。此類國家指南要求廣泛部署數位乳房X光攝影設備，以有效管理大規模篩檢項目，從而為製造商創造可預測的採購週期。例如，英國國家醫療服務體系（NHS）數位部門於2025年2月發布的《英格蘭乳癌篩檢計畫（2023-2024）》報告顯示，已有195萬名45歲及以上的女性接受了篩檢，顯示公共衛生政策顯著提高了篩檢設備的使用率。如此大規模的篩檢對於應對乳癌發生率的上升至關重要。加拿大癌症協會估計，到2025年，加拿大女性乳癌確診病例將達到31,900例，凸顯了全球對強大且便利的數位篩檢基礎設施的迫切需求。

市場挑戰

數位乳房乳房X光攝影系統所需的大量資本投入是全球數位乳房乳房X光攝影市場擴張的主要障礙。全視野數位乳房X光乳房X光攝影（FFDM）和數位乳房儲存基礎設備。因此，許多資源匱乏的醫療機構被迫繼續使用過時的類比技術，這直接阻礙了數位解決方案的廣泛應用。此外，不完善的報銷政策往往無法充分涵蓋先進成像程序的營運成本，進一步加劇了這一經濟負擔。較低的報銷率降低了設備升級的投資報酬率，導致醫療機構推遲或放棄採購計畫。例如，美國放射學會 (ACR) 報告稱，2025 年聯邦收費標準的修訂將使醫生的報銷額減少約 2.83%，這一經濟打擊進一步阻礙了影像中心投資最新乳房X光攝影技術的能力。

市場趨勢

改變市場格局的關鍵硬體趨勢之一是從2D系統轉向3D數位乳房斷層合成（DBT）的廣泛轉變。醫療機構正積極以DBT平台取代老舊設備，以提高診斷準確性，從而顯著提升製造商的收入。這一升級週期至關重要。根據Hologic公司於2024年11月發布的2024年第四季財報，乳房醫療保健領域的銷售額成長了6.4%，產品利潤率的提升直接歸功於公司3D Dimensions系統銷售的成長。隨著醫療機構越來越傾向於使用這些先進系統，斷層合成設備的部署數量正在增加，而僅支援2D成像的配置則正在逐步淘汰。此外，要求向患者清楚解釋乳房組織成分的監管變化也加速了基於密度的篩檢方案的採用。這些變化要求醫療機構向女性解釋乳房X光攝影在高密度乳房組織中的局限性，從而促進輔助成像技術的使用。這些監管要求由美國食品藥物管理局(FDA) 於 2024 年 9 月正式製定，並由《乳房X光攝影修正案最終規則》生效。因此，醫療機構現在必須在患者資訊手冊中包含特定的乳房密度評估。這項聯邦層級的標準化措施增加了對用於管理緻密乳房組織的額外影像技術的需求。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球數位乳房攝影市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 產品細分（2D全視野數位乳房攝影攝影胎兒斷層合成、3D全視野數位乳房攝影胎兒斷層合成）
  • 依最終使用者（醫院、門診手術中心和其他最終使用者）分類
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美數位乳房攝影市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲數位乳房攝影市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區數位乳房攝影市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲數位乳房攝影市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲數位乳房攝影市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球數位乳房攝影市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Hologic Inc
• GE Healthcare
• Koninklijke Philips NV
• Siemens Healthcare GmBH
• Fujifilm Corporation
• Planmed Oy
• Toshiba Medical Systems
• Metaltronica SpA

第16章 策略建議

第17章：關於研究公司及免責聲明

The global digital mammography market is projected to expand significantly, from USD 1.19 billion in 2025 to USD 2.05 billion by 2031, exhibiting a compound annual growth rate (CAGR) of 9.49%. This specialized diagnostic imaging technique employs solid-state detectors to convert X-ray energy into electrical signals, enabling the detection of breast abnormalities. Key growth factors include the increasing worldwide incidence of breast cancer, which demands effective early detection methods, coupled with the proliferation of government-sponsored screening initiatives. An aging female demographic also contributes to this demand, as advanced age is a primary risk factor for breast disease. For instance, the American Cancer Society estimated 316,950 new invasive breast cancer diagnoses in U.S. women for 2025, highlighting the urgent need for accessible screening technologies.However, the market's expansion is hindered by the substantial acquisition and operational expenses linked to digital mammography systems. These considerable financial demands present a significant obstacle to market growth, especially in developing countries where healthcare budgets are often limited and reimbursement structures for advanced diagnostic procedures may be insufficient. This economic constraint restricts the widespread adoption of digital mammography units in areas with limited resources, thus impeding the technology's global accessibility.

Market Driver

Artificial Intelligence (AI) integration in breast imaging is a pivotal driver for the Global Digital Mammography Market, significantly enhancing diagnostic accuracy and operational efficiency. By complementing human analysis with deep learning algorithms, AI helps healthcare providers reduce false positives and elevate early detection rates, thereby stimulating the uptake of advanced digital systems compatible with these sophisticated software tools. Recent clinical evidence supports this technological advantage; for instance, RadNet, Inc.'s 'AI-Supported Safeguard Review Evaluation' study in November 2025 indicated that AI-enabled workflows boosted breast cancer detection by 21.6% compared to standard 3D mammography. These advancements motivate clinics to upgrade their equipment, enabling them to provide superior care while managing increased patient loads effectively.Simultaneously, the establishment and expansion of government-funded breast cancer screening initiatives form a consistent basis for market demand. Such national directives necessitate the broad implementation of digital mammography units to manage large-scale population screening programs efficiently, leading to predictable procurement cycles for manufacturers. For example, NHS Digital's 'Breast Screening Programme, England, 2023-24' report from February 2025 revealed that 1.95 million women aged 45 and over were screened, showcasing the significant equipment usage driven by public health policies. This high volume is crucial for addressing the rising incidence of the disease; the Canadian Cancer Society estimated 31,900 breast cancer diagnoses in Canadian women for 2025, underscoring the global need for robust and accessible digital screening infrastructure.

Market Challenge

The considerable capital expenditure necessary for digital mammography systems poses a major obstacle to the expansion of the Global Digital Mammography Market. The high acquisition costs for Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) units establish significant barriers to entry, particularly in low- and middle-income countries where healthcare budgets are severely constrained. Beyond the initial hardware procurement, the overall cost of ownership is further increased by the requirement for expensive high-resolution workstations, robust data storage infrastructure, and specialized maintenance agreements. As a result, many healthcare facilities in resource-limited environments are compelled to continue using older analog technology, which directly impedes the broader adoption of digital solutions.This financial burden is exacerbated by inadequate reimbursement policies that often fail to sufficiently cover the operational costs associated with advanced imaging procedures. A reduction in payment rates decreases the return on investment for equipment upgrades, leading providers to postpone or abandon procurement initiatives. For instance, the American College of Radiology reported in 2025 that updated federal fee schedules led to an approximate 2.83% reimbursement cut for physician services, a financial setback that further hinders imaging centers' capacity to invest in contemporary mammography technologies.

Market Trends

A dominant hardware trend transforming the market is the extensive shift from 2D systems to 3D Digital Breast Tomosynthesis (DBT). Healthcare facilities are actively replacing their older units with DBT platforms to improve diagnostic accuracy, which significantly boosts revenue for manufacturers. This upgrade cycle is substantial; Hologic, Inc.'s 'Financial Results for Fourth Quarter of Fiscal 2024' report from November 2024 showed a 6.4% increase in Breast Health revenue, with product margin expansion directly attributed to increased sales of their 3D Dimensions systems. As clinics increasingly favor these advanced systems, the installed base of tomosynthesis units expands, effectively phasing out 2D-only configurations.Furthermore, the adoption of density-based screening protocols has gained momentum due to regulatory changes that mandate clear patient communication regarding breast tissue composition. These updates require providers to inform women about the limitations of mammography in dense breast tissue, thereby encouraging the use of supplemental imaging modalities. This regulatory mandate was formalized by the U.S. Food and Drug Administration (FDA) in September 2024, with enforcement beginning for requirements under the 'Final Rule to Amend the Mammography Quality Standards Act (MQSA)' that facilities include specific breast density assessments in patient lay letters. This federal standardization drives demand for the additional imaging technologies needed for managing dense breast tissue.

Key Market Players

• Hologic Inc
• GE Healthcare
• Koninklijke Philips NV
• Siemens Healthcare GmBH
• Fujifilm Corporation
• Planmed Oy
• Toshiba Medical Systems
• Metaltronica S.p.A

Report Scope

In this report, the Global Digital Mammography Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital Mammography Market, By Product

• 2D Full Field Digital Mammography Tomosynthesis
• 3D Full Field Digital Mammography Tomosynthesis

Digital Mammography Market, By End-User

• Hospitals
• Ambulatory Surgical Centers
• Other End-Users

Digital Mammography Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Mammography Market.

Available Customizations:

Global Digital Mammography Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Digital Mammography Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (2D Full Field Digital Mammography Tomosynthesis, 3D Full Field Digital Mammography Tomosynthesis)
  • 5.2.2. By End-User (Hospitals, Ambulatory Surgical Centers, Other End-Users)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Digital Mammography Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By End-User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Digital Mammography Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By End-User
  • 6.3.2. Canada Digital Mammography Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By End-User
  • 6.3.3. Mexico Digital Mammography Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By End-User

7. Europe Digital Mammography Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By End-User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Digital Mammography Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By End-User
  • 7.3.2. France Digital Mammography Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By End-User
  • 7.3.3. United Kingdom Digital Mammography Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By End-User
  • 7.3.4. Italy Digital Mammography Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By End-User
  • 7.3.5. Spain Digital Mammography Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By End-User

8. Asia Pacific Digital Mammography Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By End-User
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Digital Mammography Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By End-User
  • 8.3.2. India Digital Mammography Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By End-User
  • 8.3.3. Japan Digital Mammography Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By End-User
  • 8.3.4. South Korea Digital Mammography Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By End-User
  • 8.3.5. Australia Digital Mammography Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By End-User

9. Middle East & Africa Digital Mammography Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By End-User
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Digital Mammography Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By End-User
  • 9.3.2. UAE Digital Mammography Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By End-User
  • 9.3.3. South Africa Digital Mammography Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By End-User

10. South America Digital Mammography Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By End-User
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Digital Mammography Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By End-User
  • 10.3.2. Colombia Digital Mammography Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By End-User
  • 10.3.3. Argentina Digital Mammography Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Digital Mammography Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Hologic Inc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. GE Healthcare
• 15.3. Koninklijke Philips NV
• 15.4. Siemens Healthcare GmBH
• 15.5. Fujifilm Corporation
• 15.6. Planmed Oy
• 15.7. Toshiba Medical Systems
• 15.8. Metaltronica S.p.A

16. Strategic Recommendations

17. About Us & Disclaimer